Diagnosing pulmonary aspergillosis in patients with hematological malignancies: A multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples

European Journal of Haematology

Volumn 89, Issue 2, 2012, Pages 120-127

  Reinwald, Mark ^a   Spiess, Birgit ^a   Heinz, Werner J ^b   Vehreschild, Jörg J ^c   Lass Flörl, Cornelia ^d   Kiehl, Michael ^e   Schultheis, Beate ^f   Krause, Stefan W ^g   Wolf, Hans Heinrich ^h   Bertz, Hartmut ⁱ   Maschmeyer, Georg ^j   Hofmann, Wolf Karsten ^a   Buchheidt, Dieter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^d UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^e Frankfurt/Oder General Hospital   (Germany)

^f RUHR UNIVERSITY BOCHUM   (Germany)

^g UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^h MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

ⁱ UNIVERSITY OF FREIBURG   (Germany)

^j KLINIKUM ERNST VON BERGMANN   (Germany)

more..

Author keywords

Aspergillus; Bronchoalveolar lavage; Galactomannan; Hematological malignancies; Lung infiltrates; Polymerase chain reaction

Indexed keywords

GALACTOMANNAN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; ASPERGILLUS; BRONCHOSCOPY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; LUNG ASPERGILLOSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTICENTER STUDY (TOPIC); MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; OPTICAL DENSITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; ASPERGILLUS; BRONCHOALVEOLAR LAVAGE; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MANNANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; PULMONARY ASPERGILLOSIS; SENSITIVITY AND SPECIFICITY;

EID: 84863835368     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2012.01806.x     Document Type: Article

References (27)

1. Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010;50:1101-11.
2. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-21.
3. Maertens JA, Klont R, Masson C, et al. Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay. Clin Infect Dis 2007;44:1329-36.
4. Hachem RY, Kontoyiannis DP, Chemaly RF, Jiang Y, Reitzel R, Raad I. Utility of galactomannan enzyme immunoassay and (1, 3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus Fumigatus Infection in Hematologic Malignancy Patients. J Clin Microbiol 2009;47:129-33.
5. Maertens J, Verhaegen J, Demuynck H, Brock P, Verhoef G, Vandenberghe P, Van Eldere J, Verbist L, Boogaerts M. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis. J Clin Microbiol 1999;37:3223-8.
6. Guo YL, Chen YQ, Wang K, Qin SM, Wu C, Kong JL. Accuracy of BAL galactomannan in diagnosing invasive Aspergillosis: a bivariate metaanalysis and systematic review. Chest 2010;138:817-24.
7. Maertens J, Maertens V, Theunissen K, Meersseman W, Meersseman P, Meers S, Verbeken E, Verhoef G, Van Eldere J, Lagrou K. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary Aspergillosis in patients with hematologic diseases. Clin Infect Dis 2009;49:1688-93.
8. Spiess B, Buchheidt D, Baust C, Skladny H, Seifarth W, Zeilfelder U, Leib-Mosch C, Morz H, Hehlmann R. Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients. J Clin Microbiol 2003;41:1811-8.
9. Skladny H, Buchheidt D, Baust C, Krieg-Schneider F, Seifarth W, Leib-Mosch C, Hehlmann R. Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR. J Clin Microbiol 1999;37:3865-71.
10. Buchheidt D, Baust C, Skladny H, Ritter J, Suedhoff T, Baldus M, Seifarth W, Leib-Moesch C, Hehlmann R. Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results. Clin Infect Dis 2001;33:428-35.
11. Buchheidt D, Hummel M, Schleiermacher D, et al. Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive Aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 2004;125:196-202.
12. Luong ML, Clancy CJ, Vadnerkar A, et al. Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary Aspergillosis in lung transplant recipients. Clin Infect Dis 2011;52:1218-26.
13. Maschmeyer G, Beinert T, Buchheidt D, et al. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: guidelines of the infectious diseases working party of the German Society of Haematology and Oncology. Eur J Cancer 2009;45:2462-72.
14. [Recommendations for diagnostic bronchoalveolar lavage. German Society of Pneumology]. Pneumologie 1994;48 Suppl 1:311-23.
15. Torelli R, Sanguinetti M, Moody A, et al. Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients using a commercial real-time PCR assay: a comparison with galactomannan enzyme immunoassay for the diagnosis of invasive Aspergillosis. J Clin Microbiol 2011;49:4273-78.
16. Levy H, Horak DA, Tegtmeier BR, Yokota SB, Forman SJ. The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary Aspergillosis. Respir Med 1992;86:243-8.
17. Nguyen MH, Leather H, Clancy CJ, Cline C, Jantz MA, Kulkarni V, Wheat LJ, Wingard JR. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary Aspergillosis in patients with hematologic malignancies and stem cell transplant recipients. Biol Blood Marrow Transplant 2011;17:1043-50.
18. Tuon FF. A systematic literature review on the diagnosis of invasive Aspergillosis using Polymerase Chain Reaction (PCR) from bronchoalveolar lavage clinical samples. Rev Iberoam Micol 2007;24:89-94.
19. Hummel M, Spiess B, Cornely OA, Dittmer M, Morz H, Buchheidt D. Aspergillus PCR testing: results from a prospective PCR study within the AmBiLoad Trial. Eur J Haematol 2010;85:164-9.
20. Reichenberger F, Habicht J, Matt P, Frei R, Soler M, Bolliger CT, Dalquen P, Gratwohl A, Tamm M. Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary Aspergillosis. Bone Marrow Transplant 1999;24:1195-9.
21. Musher B, Fredricks D, Leisenring W, Balajee SA, Smith C, Marr KA. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive Aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol 2004;42:5517-22.
22. Adam O, Auperin A, Wilquin F, Bourhis JH, Gachot B, Chachaty E. Treatment with Piperacillin-Tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin Infect Dis 2004;38:917-20.
23. Lass-Florl C, Gunsilius E, Gastl G, Bonatti H, Freund MC, Gschwendtner A, Kropshofer G, Dierich MP, Petzer A. Diagnosing invasive Aspergillosis during antifungal therapy by PCR analysis of blood samples. J Clin Microbiol 2004;42:4154-7.
24. Bergeron A, Belle A, Sulahian A, Lacroix C, Chevret S, Raffoux E, Arnulf B, Socie G, Ribaud P, Tazi A. Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary Aspergillosis in patients with hematologic malignancies. Chest 2010;137:410-5.
25. Becker MJ, Lugtenburg EJ, Cornelissen JJ, Van Der Schee C, Hoogsteden HC, de Marie S. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary Aspergillosis. Br J Haematol 2003;121:448-57.
26. Lass-Florl C, Gunsilius E, Gastl G, Freund M, Dierich MP, Petzer A. Clinical evaluation of Aspergillus-PCR for detection of invasive aspergillosis in immunosuppressed patients. Mycoses 2005;48(Suppl 1):12-7.
27. Marr KA, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 2005;40:1762-9.